These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. Recommendation for subclass evaluation of TNM stage iva papillary thyroid carcinomas: T4aN1b patients are at risk for recurrence and survival. Wada N; Masudo K; Nakayama H; Suganuma N; Matsuzu K; Hirakawa S; Rino Y; Masuda M; Imada T Ann Surg Oncol; 2008 May; 15(5):1511-7. PubMed ID: 18299932 [TBL] [Abstract][Full Text] [Related]
47. [Surgical treatment of differentiated thyroid carcinoma]. Guercioni G; Siquini W; Taccaliti A; Marmorale C Ann Ital Chir; 2003; 74(5):501-9. PubMed ID: 15139704 [TBL] [Abstract][Full Text] [Related]
48. Are Evidence-Based Guidelines Reflected in Clinical Practice? An Analysis of Prospectively Collected Data of the Italian Thyroid Cancer Observatory. Lamartina L; Durante C; Lucisano G; Grani G; Bellantone R; Lombardi CP; Pontecorvi A; Arvat E; Felicetti F; Zatelli MC; Rossi R; Puxeddu E; Morelli S; Torlontano M; Crocetti U; Montesano T; Giubbini R; Orlandi F; Aimaretti G; Monzani F; Attard M; Francese C; Antonelli A; Limone P; Rossetto R; Fugazzola L; Meringolo D; Bruno R; Tumino S; Ceresini G; Centanni M; Monti S; Salvatore D; Spiazzi G; Mian C; Persani L; Barbaro D; Nicolucci A; Filetti S Thyroid; 2017 Dec; 27(12):1490-1497. PubMed ID: 29020892 [TBL] [Abstract][Full Text] [Related]
49. [Prospective therapy study in differentiated thyroid carcinoma]. Gemsenjäger E; Heitz P; Martina B Schweiz Med Wochenschr; 1995 Nov; 125(46):2226-36. PubMed ID: 8525342 [TBL] [Abstract][Full Text] [Related]
50. Outcomes of patients with differentiated thyroid carcinoma following initial therapy. Jonklaas J; Sarlis NJ; Litofsky D; Ain KB; Bigos ST; Brierley JD; Cooper DS; Haugen BR; Ladenson PW; Magner J; Robbins J; Ross DS; Skarulis M; Maxon HR; Sherman SI Thyroid; 2006 Dec; 16(12):1229-42. PubMed ID: 17199433 [TBL] [Abstract][Full Text] [Related]
51. Impact of lymph node metastasis in differentiated carcinoma of the thyroid: a matched-pair analysis. Hughes CJ; Shaha AR; Shah JP; Loree TR Head Neck; 1996; 18(2):127-32. PubMed ID: 8647677 [TBL] [Abstract][Full Text] [Related]
52. [Differentiated thyroid cancer revealed by cervical adenopathy]. Rodier JF; Janser JC Ann Endocrinol (Paris); 1997; 58(3):268-71. PubMed ID: 9239254 [No Abstract] [Full Text] [Related]
53. Application of prognostic scoring systems in differentiated thyroid carcinoma. Chaplin JM; O'Brien CJ; McNeil EB; Haghighi K Aust N Z J Surg; 1999 Sep; 69(9):625-8. PubMed ID: 10515332 [TBL] [Abstract][Full Text] [Related]
54. Papillary thyroid carcinoma: a 10 year follow-up report of the impact of therapy in 576 patients. Mazzaferri EL; Young RL Am J Med; 1981 Mar; 70(3):511-8. PubMed ID: 7211893 [TBL] [Abstract][Full Text] [Related]
55. Adolescent versus adult thyroid carcinoma. Zohar Y; Strauss M; Laurian N Laryngoscope; 1986 May; 96(5):555-9. PubMed ID: 3702570 [TBL] [Abstract][Full Text] [Related]
56. [Pro and contra lymphadenectomy in papillary and follicular thyroid gland carcinoma]. Seiler CA; Schäfer M; Büchler MW Zentralbl Chir; 2000; 125(10):835-40; discussion 840-1. PubMed ID: 11098579 [TBL] [Abstract][Full Text] [Related]
57. Outcome after treatment of high-risk papillary and non-Hürthle-cell follicular thyroid carcinoma. Taylor T; Specker B; Robbins J; Sperling M; Ho M; Ain K; Bigos ST; Brierley J; Cooper D; Haugen B; Hay I; Hertzberg V; Klein I; Klein H; Ladenson P; Nishiyama R; Ross D; Sherman S; Maxon HR Ann Intern Med; 1998 Oct; 129(8):622-7. PubMed ID: 9786809 [TBL] [Abstract][Full Text] [Related]
58. Significance of tumor capsular invasion in well-differentiated thyroid carcinomas. Furlan JC; Bedard YC; Rosen IB Am Surg; 2007 May; 73(5):484-91. PubMed ID: 17521005 [TBL] [Abstract][Full Text] [Related]
59. Differentiated thyroid carcinoma with distant metastases at presentation: prognostic factors and outcome. Haq M; Harmer C Clin Endocrinol (Oxf); 2005 Jul; 63(1):87-93. PubMed ID: 15963067 [TBL] [Abstract][Full Text] [Related]
60. Dynamic Risk Estimates of Outcome in Chinese Patients with Well-Differentiated Thyroid Cancer After Total Thyroidectomy and Radioactive Iodine Remnant Ablation. Shen FC; Hsieh CJ; Huang IC; Chang YH; Wang PW Thyroid; 2017 Apr; 27(4):531-536. PubMed ID: 28007013 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]